These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31158694)

  • 21. Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease.
    Wolk DA; Das SR; Mueller SG; Weiner MW; Yushkevich PA;
    Neurobiol Aging; 2017 Jan; 49():204-213. PubMed ID: 27836336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aging and Alzheimer's disease have dissociable effects on local and regional medial temporal lobe connectivity.
    Hrybouski S; Das SR; Xie L; Wisse LEM; Kelley M; Lane J; Sherin M; DiCalogero M; Nasrallah I; Detre J; Yushkevich PA; Wolk DA
    Brain Commun; 2023; 5(5):fcad245. PubMed ID: 37767219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
    Parker AF; Smart CM; Scarapicchia V; Gawryluk JR;
    J Alzheimers Dis; 2020; 77(3):1067-1076. PubMed ID: 32804127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging and Alzheimer's Disease Have Dissociable Effects on Medial Temporal Lobe Connectivity.
    Hrybouski S; Das SR; Xie L; Wisse LEM; Kelley M; Lane J; Sherin M; DiCalogero M; Nasrallah I; Detre JA; Yushkevich PA; Wolk DA
    medRxiv; 2023 Jan; ():. PubMed ID: 36711782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased functional connectivity within medial temporal lobe in mild cognitive impairment.
    Das SR; Pluta J; Mancuso L; Kliot D; Orozco S; Dickerson BC; Yushkevich PA; Wolk DA
    Hippocampus; 2013 Jan; 23(1):1-6. PubMed ID: 22815064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.
    Teipel SJ; Pruessner JC; Faltraco F; Born C; Rocha-Unold M; Evans A; Möller HJ; Hampel H
    J Neurol; 2006 Jun; 253(6):794-800. PubMed ID: 16511646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    Jarholm JA; Bjørnerud A; Dalaker TO; Akhavi MS; Kirsebom BE; Pålhaugen L; Nordengen K; Grøntvedt GR; Nakling A; Kalheim LF; Almdahl IS; Tecelão S; Fladby T; Selnes P
    J Alzheimers Dis; 2023; 94(1):259-279. PubMed ID: 37248900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls).
    Krasuski JS; Alexander GE; Horwitz B; Daly EM; Murphy DG; Rapoport SI; Schapiro MB
    Biol Psychiatry; 1998 Jan; 43(1):60-8. PubMed ID: 9442345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer's Disease.
    Zhao T; Quan M; Jia J
    J Alzheimers Dis; 2020; 73(4):1435-1444. PubMed ID: 31929167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum.
    Qing Z; Chen F; Lu J; Lv P; Li W; Liang X; Wang M; Wang Z; Zhang X; Zhang B;
    Hum Brain Mapp; 2021 Aug; 42(12):3950-3962. PubMed ID: 33978292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment.
    Wearn AR; Nurdal V; Saunders-Jennings E; Knight MJ; Madan CR; Fallon SJ; Isotalus HK; Kauppinen RA; Coulthard EJ
    Neuroimage; 2021 Sep; 238():118214. PubMed ID: 34116150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities.
    de Flores R; Das SR; Xie L; Wisse LEM; Lyu X; Shah P; Yushkevich PA; Wolk DA
    J Neurosci; 2022 Mar; 42(10):2131-2141. PubMed ID: 35086906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
    Baumeister H; Vogel JW; Insel PS; Kleineidam L; Wolfsgruber S; Stark M; Gellersen HM; Yakupov R; Schmid MC; Lüsebrink F; Brosseron F; Ziegler G; Freiesleben SD; Preis L; Schneider LS; Spruth EJ; Altenstein S; Lohse A; Fliessbach K; Vogt IR; Bartels C; Schott BH; Rostamzadeh A; Glanz W; Incesoy EI; Butryn M; Janowitz D; Rauchmann BS; Kilimann I; Goerss D; Munk MH; Hetzer S; Dechent P; Ewers M; Scheffler K; Wuestefeld A; Strandberg O; van Westen D; Mattsson-Carlgren N; Janelidze S; Stomrud E; Palmqvist S; Spottke A; Laske C; Teipel S; Perneczky R; Buerger K; Schneider A; Priller J; Peters O; Ramirez A; Wiltfang J; Heneka MT; Wagner M; Düzel E; Jessen F; Hansson O; Berron D
    Brain; 2024 Jul; 147(7):2400-2413. PubMed ID: 38654513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal functional connectivity within the anterior temporal network is associated with performance on declarative memory tasks.
    Gour N; Ranjeva JP; Ceccaldi M; Confort-Gouny S; Barbeau E; Soulier E; Guye M; Didic M; Felician O
    Neuroimage; 2011 Sep; 58(2):687-97. PubMed ID: 21722740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CR; Lovblad KO; Frisoni GB; Scheltens P;
    Neurobiol Aging; 2017 Apr; 52():167-182.e1. PubMed ID: 28317647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    Molinder A; Ziegelitz D; Maier SE; Eckerström C
    BMC Neurol; 2021 Jul; 21(1):289. PubMed ID: 34301202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.